Black Friday Tomorrow: buy 2, get a 3rd free on every product Buy 2 = get a 3rd free, on every product Tomorrow: 3rd one free Buy 2 = 3rd one free Starts inEnds in Shop now
Free shipping on orders from 160 €from 160 € · 3-vial Retatrutide 30 mg pack at 150 € See the packs
MyPeptide Blog
Shop Quality Certificates Blog Contact About
Order
MyPeptide
Shop Quality Certificates Blog Contact About
ORDER
MyPeptide Blog
Home Shop Quality Blog Contact My account
Order
Skip to content
MyPeptide Logo - European Research Peptide Shop
  • Home
  • Shop
  • Quality
  • Blog
  • Contact
  • About
  • My account
MyPeptide Logo - European Research Peptide Shop
  • About — MyPeptide Research Team
  • Buy KPV in Luxembourg: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy KPV in Belgium: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy KPV in France: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy retatrutide in Belgium: R3 Reta 10 mg at €59.90 | MyPeptide.eu
  • Buy GHK-Cu in Luxembourg: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy GHK-Cu in Belgium: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy GHK-Cu in France: price, COA Janoshik and delivery | MyPeptide.eu
  • Buy Research Peptides in Europe | MyPeptide.eu
  • Acquistare GHK-Cu in Italia: prezzo, COA Janoshik e consegna | MyPeptide.eu
  • Acquistare KPV in Italia: price, COA Janoshik and instructions | MyPeptide.eu
  • AHK-Cu hair: what studies say, AHK-Cu or GHK-Cu, price | MyPeptide.eu
  • Anti-Aging Peptides Europe — GHK-Cu, BPC-157 & More
  • Blog
  • Buy GHK-Cu in Ireland: Price, Janoshik COA and Delivery | MyPeptide.eu
  • Buy GHK-Cu in Malta: Price, Janoshik COA and Delivery | MyPeptide.eu
  • Buy KPV in Ireland: Price, Janoshik COA and Delivery | MyPeptide.eu
  • Buy KPV in Malta: Price, Janoshik COA and Delivery | MyPeptide.eu
  • Buy Peptides in Ireland: Supplier Guide, COA and Delivery | MyPeptide.eu
  • Buy Research Peptides in Europe
  • Buy Retatrutide in Ireland: Price, COA and Supplier | MyPeptide.eu
  • Buy Retatrutide in Malta: Price, COA and Supplier | MyPeptide.eu
  • Cagrilintide: what is it, mechanism, tests and status
  • Cagrilintide: side effects and safety
  • CagriSema: Trial results, tirzepatide and the FDA
  • Peptide calculator: reconstitution (mg/ml) and half-life | MyPeptide.eu
  • Certificates of analysis
  • COA of tesamorelin: Janoshik 98.2% analysis and verification | MyPeptide.eu
  • Cagrilintide COA: Janoshik report 99.836%
  • GHK-Cu COA: 3 Janoshik analyses, recognizing genuine GHK-Cu | MyPeptide.eu
  • KLOW COA: 4 peptides measured by Janoshik
  • KPV COA: Janoshik report 98.8%
  • MOTS-c COA: Janoshik 99.553% analysis and verification | MyPeptide.eu
  • COA retatrutide: 7 verifiable Janoshik certificates of analysis | MyPeptide.eu
  • How to verify a Janoshik Certificate of Analysis (COA) in 5 steps
  • Comprar Cagrilintide em Portugal
  • Comprar GHK-Cu en España: precio, COA Janoshik y envío | MyPeptide.eu
  • Buy KPV in Portugal: preço, COA Janoshik and purchase | MyPeptide.eu
  • Buy KPV in Spain: price, COA of Janoshik and envío | MyPeptide.eu
  • Buy Retatrutide in Portugal: preço desde 5 €/mg, COA Janoshik | MyPeptide.eu
  • Comprar Retatrutide en España: precio desde 5 €/mg, COA Janoshik | MyPeptide.eu
  • Comprar Tirzepatide em Portugal
  • Terms of Use
  • General Terms and Conditions of Sale – MyPeptide
  • Contact details – Legal notice
  • Cumpără GHK-Cu în România: preț, COA Janoshik și livrare | MyPeptide.eu
  • Cumpără KPV în România: preț, COA Janoshik și livrare | MyPeptide.eu
  • Cumpără Retatrutide în România: preț, COA și furnizor | MyPeptide.eu
  • Bacteriostatic water: uses, pharmacy, price and storage | MyPeptide.eu
  • FAQ – Frequently Asked Questions about Research Peptides
  • GHK-Cu: A Complete Guide to Copper Peptide (Research, Forms, Prices) | MyPeptide.eu
  • GHK-Cu hair: what studies say, GHK-Cu or AHK-Cu | MyPeptide.eu
  • Injectable or cream-based GHK-Cu: What forms, what are the differences? | MyPeptide.eu
  • GHK-Cu kaufen in Deutschland: Preis, Janoshik-COA & Versand | MyPeptide.eu
  • GHK-Cu kaufen in Österreich: Preis, Janoshik-COA und Zustellung | MyPeptide.eu
  • GHK-Cu kopen in Nederland: prijs, Janoshik-COA en levering | MyPeptide.eu
  • GHK-Cu kupić w Polsce: cena, certyfikat Janoshik i dostawa | MyPeptide.eu
  • GHK-Cu vásárlás Magyarországon: ár, Janoshik COA és szállítás | MyPeptide.eu
  • GLP-3: What is it? Retatrutide, a triple agonist (price, COA) | MyPeptide.eu
  • Complete Guide to NAD+: Longevity, Sirtuins, and DNA Repair
  • Complete Guide to Retatrutide: Mechanisms, Research and Clinical Results
  • Home
  • Kjøp GHK-Cu i Norge: pris, Janoshik-COA og levering | MyPeptide.eu
  • Kjøp retatrutide i Norge: pris, COA og leverandør | MyPeptide.eu
  • Kjøpe KPV i Norge: taken, Janoshik-COA and levering | MyPeptide.eu
  • KLOW: Side effects, risks and reviews
  • KLOW benefits: what studies really say
  • KLOW peptide: what is it, composition, studies and price
  • KLOW vs GLOW vs Wolverine: what are the differences?
  • Køb GHK-Cu i Danmark: pris, Janoshik-COA og levering | MyPeptide.eu
  • Køb retatrutide i Danmark: pris, COA og leverandør | MyPeptide.eu
  • Købe KPV i Danmark: taken, Janoshik-COA and levering | MyPeptide.eu
  • Köp GHK-Cu i Sverige: pris, Janoshik-COA och leverans | MyPeptide.eu
  • Köp retatrutide i Sverige: pris, COA och leverantör | MyPeptide.eu
  • Köpa KPV i Sverige: taken, Janoshik-COA och leverans | MyPeptide.eu
  • Koupit GHK-Cu v Česku: cena, COA Janoshik a doručení | MyPeptide.eu
  • Koupit KPV v Česku: cena, COA Janoshik a doručení | MyPeptide.eu
  • Koupit retatrutide v Česku: cena, COA a dodavatel | MyPeptide.eu
  • KPV: studied benefits for the gut and skin
  • KPV: What is it, how does it work, research, and its status?
  • KPV: Side effects, safety and status
  • KPV can be found in Germany: Prices, Janoshik-COA and Versand | MyPeptide.eu
  • KPV can be found in Österreich: Prices, Janoshik-COA and Delivery | MyPeptide.eu
  • KPV open in Nederland: prices, Janoshik-COA in leverage | MyPeptide.eu
  • Oral or injectable KPV: what the studies say
  • KPV or BPC-157: what are the differences?
  • KPV vásárlás Magyarországon: ár, Janoshik COA és szállítás | MyPeptide.eu
  • Kupić KPV w Polsce: cena, COA Janoshik i dostawa | MyPeptide.eu
  • Kúpiť GHK-Cu na Slovensku: cena, COA Janoshik a doručenie | MyPeptide.eu
  • Kúpiť KPV na Slovensku: cena, COA Janoshik a dručenie | MyPeptide.eu
  • Kúpiť retatrutide na Slovensku: cena, COA a dodávateľ | MyPeptide.eu
  • Kupiti GHK-Cu u Hrvatskoj: cijena, Janoshik COA i dostava | MyPeptide.eu
  • Kupiti KPV u Hrvatskoj: cijena, Janoshik COA i dostava | MyPeptide.eu
  • Kupiti Retatrutide u Hrvatskoj: cijena, COA i dobavljač | MyPeptide.eu
  • Mistä ostaa KPV:tä Suomessa? Hinta, Janoshik-COA ja toimitus | MyPeptide.eu
  • MOTS-c: What is it, effects, studies and price (complete guide) | MyPeptide.eu
  • MOTS-c: Side effects, dangers, and reviews (what we know) | MyPeptide.eu
  • MOTS-c and weight loss: metabolism, insulin, what the studies say | MyPeptide.eu
  • MOTS-c and sport: the peptide that "mimics exercise," what the research says | MyPeptide.eu
  • MOTS-c vs SS-31 (elamipretide): Two mitochondrial peptides compared | MyPeptide.eu
  • MyPeptide reviews: is it a legit site?
  • Wave to buy GHK-Cu in Portugal: preço, COA Janoshik and entrega | MyPeptide.eu
  • Osta GHK-Cu Suomesta: hinta, Janoshik-COA ja toimitus | MyPeptide.eu
  • Osta retatrutide Suomesta: hinta, COA ja toimittaja | MyPeptide.eu
  • Copper peptides: GHK-Cu, AHK-Cu, differences and uses | MyPeptide.eu
  • Pharmaceutical Grade Peptides Europe — HPLC 99%+
  • R3 shot, injection, or pen: the different forms of retatrutide | MyPeptide.eu
  • Pirkt GHK-Cu Latvijā: cena, Janoshik COA un piegāde | MyPeptide.eu
  • Pirkt KPV Latvijā: cena, Janoshik COA un piegāde | MyPeptide.eu
  • Pirkt Retatrutide Latvijā: cena, COA un piegādātājs | MyPeptide.eu
  • Pirkti GHK-Cu Lietuvoje: kaina, Janoshik COA ir pristatymas | MyPeptide.eu
  • Pirkti KPV Lietuvoje: kaina, Janoshik COA ir pristatymas | MyPeptide.eu
  • Pirkti Retatrutide Lietuvoje: kaina, COA ir tiekėjas | MyPeptide.eu
  • Shipping Policy
  • Privacy Policy – MyPeptide
  • Return and refund policy
  • GHK-Cu price in Europe: 13 sellers compared
  • Price of retatrutide (R3) in France: from €5/mg
  • R3 (retatrutide): Is it a medication? Pharmacy, prescription, tablet | MyPeptide.eu
  • Research Peptides Fast Shipping Europe — 2–5 Days
  • Retatrutide: legal status in Europe, country by country (2026)
  • Retatrutide France: supplier, prices from €5/mg, COA Janoshik | MyPeptide.eu
  • Retatrutide kaufen in Deutschland: Preis ab 5 €/mg, Janoshik-COA | MyPeptide.eu
  • Retatrutide kaufen in Österreich: Preis, COA und Anbieter | MyPeptide.eu
  • Retatrutide kopen in Nederland en België: prices, COA & leverage | MyPeptide.eu
  • Retatrutide kupić w Polsce: cena, COA i dostawca | MyPeptide.eu
  • Retatrutide Luxembourg: Price, Purchase & Reliable Supplier | MyPeptide.eu
  • Retatrutide prezzo e acquisto in Italia: da 5 €/mg, COA Janoshik | MyPeptide.eu
  • Retatrutide vásárlás Magyarországon: ár, COA és beszállító | MyPeptide.eu
  • Retatrutide vs. cagrilintide: Differences, mechanisms, and trials | MyPeptide.eu
  • Retatrutide vs tesamorelin: differences, targets, and studies | MyPeptide.eu
  • Tesamorelin: What is it, studies, status and price | MyPeptide.eu
  • Tesamorelin: Side effects, dangers, and reviews (clinical trials) | MyPeptide.eu
  • Tesamorelin and visceral (belly) fat: what the trials show | MyPeptide.eu
  • Tesamorelin and bodybuilding: what the research really says | MyPeptide.eu
  • Weight Loss Peptides Europe — Retatrutide & More
  • Αγορά GHK-Cu στην Ελλάδα: Τιμή, COA Janoshik και Παράδοση | MyPeptide.eu
  • Αγορά GHK-Cu στην Κύπρο: Τιμή, COA Janoshik και Παράδοση | MyPeptide.eu
  • Αγορά KPV στην Ελλάδα: Τιμή, COA Janoshik και Παράδοση | MyPeptide.eu
  • Αγορά KPV στην Κύπρο: Τιμή, COA Janoshik και Παράδοση | MyPeptide.eu
  • Αγορά Retatrutide στην Ελλάδα: Τιμή, COA και Προμηθευτής | MyPeptide.eu
  • Αγορά Retatrutide στην Κύπρο: Τιμή, COA και Προμηθευτής | MyPeptide.eu
  • Buy Research Peptides — Retatrutide, GHK-Cu, NAD+ | MyPeptide.eu
  • Cart
  • Quality
  • Checkout
  • Contact
  • My account
By Samayyy / July 13, 2026
Science
11-minute read

Brenipatide (LY3537031): Eli Lilly's monthly dual GIP/GLP-1 agonist

Brenipatide (development code LY3537031) is a dual agonist of the GIP and GLP-1 receptors developed by Eli Lilly. Its distinguishing feature is a prolonged half-life designed for administration monthlyand a unique clinical positioning focused on addiction and psychiatry rather than just weight loss.

1x/month
Administration (design)
Double
GIP/GLP-1 Agonist
Ph.3
Alcohol use disorder
~1,100
Participants (RENEW-ALC-1)

What is Brenipatide?

Brenipatide (international nonproprietary name; development codes LY3537031 / LY-3537031) is a research peptide developed by Eli Lilly. It belongs to the class of dual incretin agonists, like tirzepatide, but differs in its pharmacokinetics and development strategy. It simultaneously activates two receptors:

  • GLP-1 Receptor (Glucagon-Like Peptide-1) — regulation of appetite, slowing of gastric emptying, stimulation of glucose-dependent insulin secretion
  • GIP Receptor (Glucose-Dependent Insulinotropic Polypeptide) — potentiation of the insulinotropic effect, modulation of lipid metabolism in adipose tissue

Where tirzepatide, semaglutide and retatrutide require administration weeklyBrenipatide was engineered to last much longer in the body — hence the objective of an injection once a month.

🔬 Molecular Design

Brenipatide is administered subcutaneously. Its long duration of action is thought to be based on structural modifications that confer increased resistance to enzymatic degradation (notably the replacement of certain susceptible residues), significantly prolonging its half-life compared to weekly incretins. The complete sequence and exact molecular mass have not been published in detail by the manufacturer.

Mechanism of action: the dual incretin GIP/GLP-1

Co-activation of GLP-1 and GIP receptors produces synergistic effects on satiety, insulin sensitivity and energy expenditure — greater than what a mono-agonist GLP-1 can achieve.

Action on the GLP-1 receptor — appetite and blood sugar

Activation of GLP-1R in the hypothalamus and brainstem induces:

  • A reduction in food intake and an increase in satiety signals
  • A slowing of gastric emptying
  • Glucose-dependent insulin stimulation and postprandial glucagon reduction

Action on the GIP receptor — metabolic potentiation

Activation of GIPR complements the GLP-1 pathway by potentiating the glucose-dependent insulinotropic effect and modulating lipid storage and mobilization in adipocytes. This dual stimulation aims for better glycemic control and greater metabolic efficiency than monoagonists.

A central action on the reward circuits

This is the most original aspect of Brenipatide. GIP/GLP-1 signaling modulates dopaminergic reward pathways in the central nervous system. It is precisely this central action—on the mechanisms of craving and compulsion—that Eli Lilly is exploring for neuropsychiatric and addiction indications, beyond metabolism.

The Brenipatide signature: monthly administration

The extended half-life is not a minor detail: it changes the very nature of the potential use. A monthly rather than weekly injection greatly reduces the burden of adherence — a crucial issue in populations where regular medication intake is difficult (addictions, psychiatric disorders).

💡 Why monthly dosing is strategic

In addiction or mood disorders, adherence to weekly treatment is a major obstacle. A long-acting molecule, administered once a month, directly targets this weakness—hence Eli Lilly's choice of these indications for Brenipatide.

A novel clinical approach: addiction and psychiatry

Unlike retatrutide or tirzepatide, which were initially developed for obesity and diabetes, Eli Lilly is primarily targeting the central nervous system with Brenipatide. The clinical program includes, in particular:

  • Alcohol use disorder — Phase 3 trials RENEW-ALC-1 and RENEW-ALC-2 (moderate to severe and risky use)
  • Opioid use disorder — dedicated clinical study
  • Psychiatric disorders — bipolar disorder, smoking cessation and relapse prevention
  • Other avenues explored — asthma (phase 2), cardiovascular, hepatic, metabolic disorders and obesity

The RENEW-ALC-1 trial (NCT07219966) is a phase 3, randomized, double-blind, placebo-controlled study planning to enroll approximately 1,100 participants with moderate to severe alcohol use disorder, with a follow-up of approximately 56 weeks. Recruitment began in late 2025.

Brenipatide vs Tirzepatide vs Retatrutide

Positioning Brenipatide among the multi-receptor agonists of incretins clarifies its uniqueness:

Molecule Receptor targets Frequency Lead indication Status
Semaglutide GLP-1 Weekly Obesity / Type 2 diabetes Marketed
Tirzepatide GIP / GLP-1 Weekly Obesity / Type 2 diabetes Marketed
Retatrutide GLP-1 / GIP / Glucagon Weekly Obesity Phase 3
Brenipatide GIP / GLP-1 Monthly Addiction / alcohol Phase 3

Applications in research

In the laboratory, Brenipatide is of interest to several areas of preclinical and basic research:

  • Study of GIP/GLP-1 co-signaling and its synergistic metabolic effects
  • Models of the modulation of dopaminergic reward circuits (addiction, compulsion)
  • Research on long-acting peptides and half-life engineering
  • Comparison of double versus triple incretin profiles (vs tirzepatide and retatrutide)

Key points to remember

  • Brenipatide (LY3537031) is a dual GIP/GLP-1 agonist developed by Eli Lilly.
  • Its signature is a monthly administration, made possible by a greatly extended half-life.
  • Its development primarily targets addiction and psychiatry (alcohol, opioids, bipolar disorder, tobacco), through the action of incretins on reward circuits
  • Phase 3 trials RENEW-ALC-1 / RENEW-ALC-2 on alcohol use disorder, recruitment began in late 2025
  • The exact sequence and molecular mass have not yet been published.
  • No phase 3 efficacy results are available to date.
Warning : This article is provided for scientific informational purposes only. Brenipatide is an experimental research compound and is not approved as a medicine. The information presented is derived from public sources (clinical trial registries, literature) and does not constitute medical advice. All MyPeptide.eu products are intended exclusively for scientific laboratory research.

Scientific sources: Brenipatide — Wikipedia · NCT07219966 — RENEW-ALC-1 (Phase 3) · AdisInsight — Brenipatide (Eli Lilly)

📦 Buy Brenipatide in Europe

Available at MyPeptide.eu • Janoshik-certified HPLC 99%+ purity • Batch COA • Discreet delivery in 2 to 5 business days in Europe

Previous

Cagrilintide: The Amylin Analogue That Complements GLP-1 — Scientific Guide

Following

Eloralintide (LY3841136): Eli Lilly's Amylin Agonist — Scientific Guide

Leave a comment Cancel reply

Your email address will not be published. Required fields are indicated with an asterisk (*). *

Warning : The products offered on MyPeptide.eu are intended exclusively for scientific research in the laboratory.

© 2026 MyPeptide.eu — All rights reserved · Designed in Europe · GDPR compliant
Certificates of AnalysisIs MyPeptide legit?Terms & ConditionsPrivacy PolicyTerms of ServiceReturn & Refund PolicyShipping PolicyLegal Notice
100% secure paymentVisaApple PayGoogle Pay
FRENDEITESPTNLPLSV
Back to top